OPS
TEVA icon

Orion Portfolio Solutions’s Teva Pharmaceuticals TEVA Stock Holding History

Orion Portfolio Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$156K Sell
10,133
-2,169
-18% -$38.7K ﹤0.01% 1830
2024
Q4 		$271K Buy
12,302
+1,310
+12% +$23.8K ﹤0.01% 1603
2024
Q3 		$198K Buy
+10,992
New +$192K ﹤0.01% 1718
2020
Q3 		– Sell
-154
Closed -$2K – 1874
2020
Q2 		$2K Buy
154
+150
+3,750% +$1.7K ﹤0.01% 1832
2020
Q1 		$0 Hold
4
– – ﹤0.01% 2296
2019
Q4 		$0 Buy
+4
New +$36 ﹤0.01% 1948

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Orion Portfolio Solutions's TEVA Position: Q1 2025 in Review

Orion Portfolio Solutions reduced its Teva Pharmaceuticals (TEVA) stake by 18% in Q1 2025, selling an estimated $38.7K and leaving 10,133 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #1830.

Orion Portfolio Solutions first reported a position in TEVA in Q4 2019 and has held it in 6 quarters since. The position peaked at $271K in Q4 2024. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • Orion Portfolio Solutions held 10,133 shares of Teva Pharmaceuticals worth $156K as of Q1 2025.
  • Orion Portfolio Solutions sold 2,169 Teva Pharmaceuticals shares in Q1 2025, an estimated $38.7K.
  • Teva Pharmaceuticals made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1830 holding.
  • Orion Portfolio Solutions first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
  • Orion Portfolio Solutions's Teva Pharmaceuticals position peaked at $271K in Q4 2024.
  • 560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.